⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Cariprazine

کاریپرازین

⚠ Unverified

🧠 Nervous SystemAtypical antipsychotic

🤰 Pregnancy:Dangerous / avoid 🤱 Breastfeeding:Use with caution 👶 Children:Dangerous / avoid 👴 Older adults:Dangerous / avoid 🇮🇷 Not found in Iran list ⛔ 1 contraindications 🇺🇸 FDA approved (NDA) NDA204370 ATC N05AX15

Market / country: 🇺🇸 USA

Vraylar (US)

🧮 Dose calculator

Disease / regimen

Schizophrenia · Regimen source: FDA Vraylar · 2.2

• May increase to 3 mg on day 2. Long half-life: dose changes take weeks to show. FDA Vraylar · 2.2 FDA Vraylar · 2.1

Formulation

Age *

Weight (kg) (optional)

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

⛔ History of hypersensitivity to cariprazine. FDA Vraylar · 4

Warnings

• Boxed warning: increased mortality in elderly patients with dementia-related psychosis; suicidal thoughts in children and young adults. FDA Vraylar · Boxed Warning

Formulations

1.5 mg capsule — capsule 🇺🇸 USA FDA Vraylar · 3
3 mg capsule — capsule 🇺🇸 USA FDA Vraylar · 3
4.5 mg capsule — capsule 🇺🇸 USA FDA Vraylar · 3
6 mg capsule — capsule 🇺🇸 USA FDA Vraylar · 3

👥 Special populations

🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Vraylar · 8.1
“Based on animal data, VRAYLAR may cause fetal harm.”
🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Vraylar · 8.2
“Risk Summary Lactation studies have not been conducted to assess the presence of cariprazine in human milk, the effects on the breastfed infant, or the effects on milk production.”
👶 ChildrenDangerous / avoid
Boxed warning in the label about children. FDA Vraylar · Boxed Warning
“Suicidal Thoughts and Behaviors Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies.”
👴 Older adultsDangerous / avoid
Label: serious warning or avoid in older adults. FDA Vraylar · Boxed Warning
“Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.”
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)NDA204370
DailyMed (FDA label)FDA Vraylar
MedlinePlus (NIH)Cariprazine
WHO ATC/DDDN05AX15
Darooyab (Iran)❌ None

🇮🇷 Not found in Iran list Darooyab · search

Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Vraylar · 3 FDA Vraylar · 2.2 FDA Vraylar · 2.1 FDA Vraylar · 2.3 FDA Vraylar · 2.4 FDA Vraylar · 2.5 FDA Vraylar · 4 FDA Vraylar · Boxed Warning FDA Vraylar · SPL approval / marketing category FDA Vraylar · 8.1 FDA Vraylar · 8.2
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · search
Clinical review⚠ Unverified